Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas

J Zeng, AP See, J Phallen, CM Jackson… - International Journal of …, 2013 - Elsevier
PURPOSE: Glioblastoma multiforme (GBM) is the most common primary brain tumor in
adults, and radiation is one of the main treatment modalities. However, cure rates remain low …

Mechanisms of immunotherapy resistance: lessons from glioblastoma

CM Jackson, J Choi, M Lim - Nature immunology, 2019 - nature.com
Glioblastoma (GBM) is the deadliest form of brain cancer, with a median survival of less than
2 years despite surgical resection, radiation, and chemotherapy. GBM’s rapid progression, …

Anti–PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM

…, J Phallen, CK Park, CM Jackson… - Science translational …, 2016 - science.org
The immunosuppressive effects of chemotherapy present a challenge for designing effective
cancer immunotherapy strategies. We hypothesized that although systemic chemotherapy (…

Trigeminal neuralgia: current approaches and emerging interventions

R Xu, ME Xie, CM Jackson - Journal of pain research, 2021 - Taylor & Francis
Trigeminal neuralgia (TN) has been described in the literature as one of the most debilitating
presentations of orofacial pain. This review summarizes over 150 years of collective clinical …

Clinical trials investigating immune checkpoint blockade in glioblastoma

R Maxwell, CM Jackson, M Lim - Current treatment options in oncology, 2017 - Springer
Opinion statement Immune checkpoint inhibitors have changed the landscape of cancer
immunotherapy and are being integrated into the standard of care for a variety of solid and …

[HTML][HTML] STAT3 activation in glioblastoma: biochemical and therapeutic implications

JE Kim, M Patel, J Ruzevick, CM Jackson, M Lim - Cancers, 2014 - mdpi.com
Signal transducer and activator of transcription 3 (STAT3) is a potent regulator of gliomagenesis
through its induction of angiogenesis, host immunosuppression, and tumor invasion. …

Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment

…, AS Luksik, T Garzon-Muvdi, CM Jackson… - Journal of neuro …, 2019 - Springer
Background Emerging evidence suggests that myeloid cells play a critical role in glioblastoma
(GBM) immunosuppression. Disappointing results of recent checkpoint inhibitor trials …

[HTML][HTML] The translational potential of microglia and monocyte-derived macrophages in ischemic stroke

…, KR Ran, JE Kim, R Xu, RP Lee, CM Jackson - Frontiers in …, 2022 - frontiersin.org
The immune response to ischemic stroke is an area of study that is at the forefront of stroke
research and presents promising new avenues for treatment development. Upon cerebral …

[HTML][HTML] Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer

S Wada, CM Jackson, K Yoshimura, HR Yen… - Journal of translational …, 2013 - Springer
Background The FDA recently approved an anti-CTLA-4 antibody (Iplimumab) for the
treatment of metastatic melanoma. This decision was based on Phase III results, which …

Systemic tolerance mediated by melanoma brain tumors is reversible by radiotherapy and vaccination

CM Jackson, CM Kochel, CJ Nirschl, NM Durham… - Clinical Cancer …, 2016 - AACR
Purpose: Immune responses to antigens originating in the central nervous system (CNS)
are generally attenuated, as collateral damage can have devastating consequences. The …